Interestingly alterations of ZNRF3 and CTNNB1 are completely exclusive in ACC (16), suggesting that ZNRF3 alterations might play a crucial role in tumorigenesis by activating also the Wnt/β-catenin signaling pathway. The gene discussed is CTNNB1; the disease is adrenal cortex carcinoma.